世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
 Ventricular Assist Device - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Ventricular Assist Device was estimated to be worth US$ 1546 million in 2024 and is forecast to a readjusted size of US$ 2651 million by 2031 with a CAGR of 8.1% during the fo... もっと見る
※当ページの内容はウェブ更新時の情報です。
SummaryThe global market for Ventricular Assist Device was estimated to be worth US$ 1546 million in 2024 and is forecast to a readjusted size of US$ 2651 million by 2031 with a CAGR of 8.1% during the forecast period 2025-2031.Ventricular assist devices are mechanical pumps used to support cardiac circulation in patients who have weakened hearts. A ventricular assist device (VAD) is an electromechanical device for assisting cardiac circulation, which is used either to partially or to completely replace the function of a failing heart. The function of VADs is different from that of artificial cardiac pacemakers; some are for short-term use, typically for patients recovering from myocardial infarction (heart attack) and for patients recovering from cardiac surgery; some are for long-term use (months to years to perpetuity), typically for patients suffering from advanced heart failure. Market Driver: The growing prevalence of heart failure and cardiovascular diseases is a key driver for the Ventricular Assist Device (VAD) market. As the global aging population increases, so does the number of patients suffering from end-stage heart failure, leading to a higher demand for VADs as both a bridge-to-transplant and destination therapy. Additionally, advancements in VAD technology, such as smaller, more durable, and biocompatible devices with reduced complications, have improved patient outcomes and expanded the adoption of these devices. Government initiatives, increasing healthcare expenditures, and rising awareness of mechanical circulatory support systems further fuel market growth. Market Challenge: Despite its growth, the VAD market faces significant challenges, primarily related to high costs and surgical risks. The implantation procedure for VADs is complex, requiring skilled surgeons and advanced medical infrastructure, which limits accessibility, especially in developing regions. Moreover, post-implantation complications, such as infections, thromboembolism, and device malfunction, remain concerns, necessitating continuous monitoring and long-term patient management. Regulatory hurdles and reimbursement limitations in certain countries also pose barriers to widespread adoption, slowing market expansion. This report aims to provide a comprehensive presentation of the global market for Ventricular Assist Device, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Ventricular Assist Device by region & country, by Type, and by Application. The Ventricular Assist Device market size, estimations, and forecasts are provided in terms of sales volume (Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ventricular Assist Device. Market Segmentation By Company AbioMed Abbott (Thoratec) Medtronic (HeartWare) Berlin Heart Evaheart CH Biomedical ROCOR Medical coretech medical BiVACOR CorWave Segment by Type LVADs RVADs BIVADs Segment by Application Bridge-to-transplant (BTT) Destination Therapy (DT) Other By Region North America United States Canada Asia-Pacific China Japan South Korea Southeast Asia India Australia Rest of Asia-Pacific Europe Germany France U.K. Italy Netherlands Nordic Countries Rest of Europe Latin America Mexico Brazil Rest of Latin America Middle East & Africa Turkey Saudi Arabia UAE Rest of MEA Chapter Outline Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry. Chapter 2: Detailed analysis of Ventricular Assist Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc. Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments. Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets. Chapter 5: Sales, revenue of Ventricular Assist Device in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world. Chapter 6: Sales, revenue of Ventricular Assist Device in country level. It provides sigmate data by Type, and by Application for each country/region. Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc. Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry. Chapter 9: Conclusion. Table of Contents1 Market Overview1.1 Ventricular Assist Device Product Introduction 1.2 Global Ventricular Assist Device Market Size Forecast 1.2.1 Global Ventricular Assist Device Sales Value (2020-2031) 1.2.2 Global Ventricular Assist Device Sales Volume (2020-2031) 1.2.3 Global Ventricular Assist Device Sales Price (2020-2031) 1.3 Ventricular Assist Device Market Trends & Drivers 1.3.1 Ventricular Assist Device Industry Trends 1.3.2 Ventricular Assist Device Market Drivers & Opportunity 1.3.3 Ventricular Assist Device Market Challenges 1.3.4 Ventricular Assist Device Market Restraints 1.4 Assumptions and Limitations 1.5 Study Objectives 1.6 Years Considered 2 Competitive Analysis by Company 2.1 Global Ventricular Assist Device Players Revenue Ranking (2024) 2.2 Global Ventricular Assist Device Revenue by Company (2020-2025) 2.3 Global Ventricular Assist Device Players Sales Volume Ranking (2024) 2.4 Global Ventricular Assist Device Sales Volume by Company Players (2020-2025) 2.5 Global Ventricular Assist Device Average Price by Company (2020-2025) 2.6 Key Manufacturers Ventricular Assist Device Manufacturing Base and Headquarters 2.7 Key Manufacturers Ventricular Assist Device Product Offered 2.8 Key Manufacturers Time to Begin Mass Production of Ventricular Assist Device 2.9 Ventricular Assist Device Market Competitive Analysis 2.9.1 Ventricular Assist Device Market Concentration Rate (2020-2025) 2.9.2 Global 5 and 10 Largest Manufacturers by Ventricular Assist Device Revenue in 2024 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ventricular Assist Device as of 2024) 2.10 Mergers & Acquisitions, Expansion 3 Segmentation by Type 3.1 Introduction by Type 3.1.1 LVADs 3.1.2 RVADs 3.1.3 BIVADs 3.2 Global Ventricular Assist Device Sales Value by Type 3.2.1 Global Ventricular Assist Device Sales Value by Type (2020 VS 2024 VS 2031) 3.2.2 Global Ventricular Assist Device Sales Value, by Type (2020-2031) 3.2.3 Global Ventricular Assist Device Sales Value, by Type (%) (2020-2031) 3.3 Global Ventricular Assist Device Sales Volume by Type 3.3.1 Global Ventricular Assist Device Sales Volume by Type (2020 VS 2024 VS 2031) 3.3.2 Global Ventricular Assist Device Sales Volume, by Type (2020-2031) 3.3.3 Global Ventricular Assist Device Sales Volume, by Type (%) (2020-2031) 3.4 Global Ventricular Assist Device Average Price by Type (2020-2031) 4 Segmentation by Application 4.1 Introduction by Application 4.1.1 Bridge-to-transplant (BTT) 4.1.2 Destination Therapy (DT) 4.1.3 Other 4.2 Global Ventricular Assist Device Sales Value by Application 4.2.1 Global Ventricular Assist Device Sales Value by Application (2020 VS 2024 VS 2031) 4.2.2 Global Ventricular Assist Device Sales Value, by Application (2020-2031) 4.2.3 Global Ventricular Assist Device Sales Value, by Application (%) (2020-2031) 4.3 Global Ventricular Assist Device Sales Volume by Application 4.3.1 Global Ventricular Assist Device Sales Volume by Application (2020 VS 2024 VS 2031) 4.3.2 Global Ventricular Assist Device Sales Volume, by Application (2020-2031) 4.3.3 Global Ventricular Assist Device Sales Volume, by Application (%) (2020-2031) 4.4 Global Ventricular Assist Device Average Price by Application (2020-2031) 5 Segmentation by Region 5.1 Global Ventricular Assist Device Sales Value by Region 5.1.1 Global Ventricular Assist Device Sales Value by Region: 2020 VS 2024 VS 2031 5.1.2 Global Ventricular Assist Device Sales Value by Region (2020-2025) 5.1.3 Global Ventricular Assist Device Sales Value by Region (2026-2031) 5.1.4 Global Ventricular Assist Device Sales Value by Region (%), (2020-2031) 5.2 Global Ventricular Assist Device Sales Volume by Region 5.2.1 Global Ventricular Assist Device Sales Volume by Region: 2020 VS 2024 VS 2031 5.2.2 Global Ventricular Assist Device Sales Volume by Region (2020-2025) 5.2.3 Global Ventricular Assist Device Sales Volume by Region (2026-2031) 5.2.4 Global Ventricular Assist Device Sales Volume by Region (%), (2020-2031) 5.3 Global Ventricular Assist Device Average Price by Region (2020-2031) 5.4 North America 5.4.1 North America Ventricular Assist Device Sales Value, 2020-2031 5.4.2 North America Ventricular Assist Device Sales Value by Country (%), 2024 VS 2031 5.5 Europe 5.5.1 Europe Ventricular Assist Device Sales Value, 2020-2031 5.5.2 Europe Ventricular Assist Device Sales Value by Country (%), 2024 VS 2031 5.6 Asia Pacific 5.6.1 Asia Pacific Ventricular Assist Device Sales Value, 2020-2031 5.6.2 Asia Pacific Ventricular Assist Device Sales Value by Region (%), 2024 VS 2031 5.7 South America 5.7.1 South America Ventricular Assist Device Sales Value, 2020-2031 5.7.2 South America Ventricular Assist Device Sales Value by Country (%), 2024 VS 2031 5.8 Middle East & Africa 5.8.1 Middle East & Africa Ventricular Assist Device Sales Value, 2020-2031 5.8.2 Middle East & Africa Ventricular Assist Device Sales Value by Country (%), 2024 VS 2031 6 Segmentation by Key Countries/Regions 6.1 Key Countries/Regions Ventricular Assist Device Sales Value Growth Trends, 2020 VS 2024 VS 2031 6.2 Key Countries/Regions Ventricular Assist Device Sales Value and Sales Volume 6.2.1 Key Countries/Regions Ventricular Assist Device Sales Value, 2020-2031 6.2.2 Key Countries/Regions Ventricular Assist Device Sales Volume, 2020-2031 6.3 United States 6.3.1 United States Ventricular Assist Device Sales Value, 2020-2031 6.3.2 United States Ventricular Assist Device Sales Value by Type (%), 2024 VS 2031 6.3.3 United States Ventricular Assist Device Sales Value by Application, 2024 VS 2031 6.4 Europe 6.4.1 Europe Ventricular Assist Device Sales Value, 2020-2031 6.4.2 Europe Ventricular Assist Device Sales Value by Type (%), 2024 VS 2031 6.4.3 Europe Ventricular Assist Device Sales Value by Application, 2024 VS 2031 6.5 China 6.5.1 China Ventricular Assist Device Sales Value, 2020-2031 6.5.2 China Ventricular Assist Device Sales Value by Type (%), 2024 VS 2031 6.5.3 China Ventricular Assist Device Sales Value by Application, 2024 VS 2031 6.6 Japan 6.6.1 Japan Ventricular Assist Device Sales Value, 2020-2031 6.6.2 Japan Ventricular Assist Device Sales Value by Type (%), 2024 VS 2031 6.6.3 Japan Ventricular Assist Device Sales Value by Application, 2024 VS 2031 6.7 South Korea 6.7.1 South Korea Ventricular Assist Device Sales Value, 2020-2031 6.7.2 South Korea Ventricular Assist Device Sales Value by Type (%), 2024 VS 2031 6.7.3 South Korea Ventricular Assist Device Sales Value by Application, 2024 VS 2031 6.8 Southeast Asia 6.8.1 Southeast Asia Ventricular Assist Device Sales Value, 2020-2031 6.8.2 Southeast Asia Ventricular Assist Device Sales Value by Type (%), 2024 VS 2031 6.8.3 Southeast Asia Ventricular Assist Device Sales Value by Application, 2024 VS 2031 6.9 India 6.9.1 India Ventricular Assist Device Sales Value, 2020-2031 6.9.2 India Ventricular Assist Device Sales Value by Type (%), 2024 VS 2031 6.9.3 India Ventricular Assist Device Sales Value by Application, 2024 VS 2031 7 Company Profiles 7.1 AbioMed 7.1.1 AbioMed Company Information 7.1.2 AbioMed Introduction and Business Overview 7.1.3 AbioMed Ventricular Assist Device Sales, Revenue, Price and Gross Margin (2020-2025) 7.1.4 AbioMed Ventricular Assist Device Product Offerings 7.1.5 AbioMed Recent Development 7.2 Abbott (Thoratec) 7.2.1 Abbott (Thoratec) Company Information 7.2.2 Abbott (Thoratec) Introduction and Business Overview 7.2.3 Abbott (Thoratec) Ventricular Assist Device Sales, Revenue, Price and Gross Margin (2020-2025) 7.2.4 Abbott (Thoratec) Ventricular Assist Device Product Offerings 7.2.5 Abbott (Thoratec) Recent Development 7.3 Medtronic (HeartWare) 7.3.1 Medtronic (HeartWare) Company Information 7.3.2 Medtronic (HeartWare) Introduction and Business Overview 7.3.3 Medtronic (HeartWare) Ventricular Assist Device Sales, Revenue, Price and Gross Margin (2020-2025) 7.3.4 Medtronic (HeartWare) Ventricular Assist Device Product Offerings 7.3.5 Medtronic (HeartWare) Recent Development 7.4 Berlin Heart 7.4.1 Berlin Heart Company Information 7.4.2 Berlin Heart Introduction and Business Overview 7.4.3 Berlin Heart Ventricular Assist Device Sales, Revenue, Price and Gross Margin (2020-2025) 7.4.4 Berlin Heart Ventricular Assist Device Product Offerings 7.4.5 Berlin Heart Recent Development 7.5 Evaheart 7.5.1 Evaheart Company Information 7.5.2 Evaheart Introduction and Business Overview 7.5.3 Evaheart Ventricular Assist Device Sales, Revenue, Price and Gross Margin (2020-2025) 7.5.4 Evaheart Ventricular Assist Device Product Offerings 7.5.5 Evaheart Recent Development 7.6 CH Biomedical 7.6.1 CH Biomedical Company Information 7.6.2 CH Biomedical Introduction and Business Overview 7.6.3 CH Biomedical Ventricular Assist Device Sales, Revenue, Price and Gross Margin (2020-2025) 7.6.4 CH Biomedical Ventricular Assist Device Product Offerings 7.6.5 CH Biomedical Recent Development 7.7 ROCOR Medical 7.7.1 ROCOR Medical Company Information 7.7.2 ROCOR Medical Introduction and Business Overview 7.7.3 ROCOR Medical Ventricular Assist Device Sales, Revenue, Price and Gross Margin (2020-2025) 7.7.4 ROCOR Medical Ventricular Assist Device Product Offerings 7.7.5 ROCOR Medical Recent Development 7.8 coretech medical 7.8.1 coretech medical Company Information 7.8.2 coretech medical Introduction and Business Overview 7.8.3 coretech medical Ventricular Assist Device Sales, Revenue, Price and Gross Margin (2020-2025) 7.8.4 coretech medical Ventricular Assist Device Product Offerings 7.8.5 coretech medical Recent Development 7.9 BiVACOR 7.9.1 BiVACOR Company Information 7.9.2 BiVACOR Introduction and Business Overview 7.9.3 BiVACOR Ventricular Assist Device Sales, Revenue, Price and Gross Margin (2020-2025) 7.9.4 BiVACOR Ventricular Assist Device Product Offerings 7.9.5 BiVACOR Recent Development 7.10 CorWave 7.10.1 CorWave Company Information 7.10.2 CorWave Introduction and Business Overview 7.10.3 CorWave Ventricular Assist Device Sales, Revenue, Price and Gross Margin (2020-2025) 7.10.4 CorWave Ventricular Assist Device Product Offerings 7.10.5 CorWave Recent Development 8 Industry Chain Analysis 8.1 Ventricular Assist Device Industrial Chain 8.2 Ventricular Assist Device Upstream Analysis 8.2.1 Key Raw Materials 8.2.2 Raw Materials Key Suppliers 8.2.3 Manufacturing Cost Structure 8.3 Midstream Analysis 8.4 Downstream Analysis (Customers Analysis) 8.5 Sales Model and Sales Channels 8.5.1 Ventricular Assist Device Sales Model 8.5.2 Sales Channel 8.5.3 Ventricular Assist Device Distributors 9 Research Findings and Conclusion 10 Appendix 10.1 Research Methodology 10.1.1 Methodology/Research Approach 10.1.1.1 Research Programs/Design 10.1.1.2 Market Size Estimation 10.1.1.3 Market Breakdown and Data Triangulation 10.1.2 Data Source 10.1.2.1 Secondary Sources 10.1.2.2 Primary Sources 10.2 Author Details 10.3 Disclaimer
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（医療機器）の最新刊レポート
QYResearch社の 医療機器・消耗品分野 での最新刊レポート
本レポートと同じKEY WORD（device）の最新刊レポート
よくあるご質問QYResearch社はどのような調査会社ですか?QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。 QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
|
